HB2078 - 512R

Be it enacted by the Legislature of the State of Arizona:

Section 1. Title 20, chapter 4, article 3, Arizona Revised Statutes, is amended by adding section 20-841.10, to read:

START_STATUTE20-841.10. Cancer treatment medications; cost‑sharing; definition

A. A contract that is issued, delivered or renewed by a corporation on or after January 1, 2016, that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and that provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.

B. A corporation may not avoid compliance with subsection A of this section by:

1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.

2. Reclassifying benefits with respect to cancer treatment medications for compliance with subsection A of this section.

C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.

D. This section may not be construed to prohibit an insurer requiring a higher copayment, deductible or coinsurance to anti-cancer medication if the increase is applied to comparable medical or pharmaceutical benefits under the policy, certificate, contract or plan. END_STATUTE

Sec. 2. Title 20, chapter 4, article 9, Arizona Revised Statutes, is amended by adding section 20-1057.14, to read:

START_STATUTE20-1057.14. Cancer treatment medications; cost‑sharing; definition

A. An evidence of coverage that is issued, delivered or renewed by a health care services organization on or after January 1, 2016, that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and that provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.

B. A health care services organization may not avoid compliance with subsection A of this section by:

1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.

2. Reclassifying benefits with respect to cancer treatment medications for compliance with subsection A of this section.

C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.

Sec. 3. Title 20, chapter 6, article 4, Arizona Revised Statutes, is amended by adding section 20-1376.05, to read:

START_STATUTE20-1376.05. Cancer treatment medications; cost‑sharing; definition

A. A disability insurance policy that is issued, delivered or renewed by a disability insurer on or after January 1, 2016, that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and that provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.

B. A disability insurer may not avoid compliance with subsection A of this section by:

1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.

2. Reclassifying benefits with respect to cancer treatment medications for compliance with subsection A of this section.

C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.

Sec. 4. Title 20, chapter 6, article 5, Arizona Revised Statutes, is amended by adding section 20-1406.06, to read:

START_STATUTE20-1406.06. Cancer treatment medications; cost‑sharing; definition

A. A group or blanket disability policy that is issued, delivered or renewed by a group or blanket disability insurer on or after January 1, 2016, that provides coverage for cancer treatment medications that are injected or intravenously administered by a health care provider and that provides coverage for patient‑administered cancer treatment medications, including medications that are orally administered or self‑injected, may not require a higher copayment, deductible or coinsurance amount for patient‑administered cancer treatment medications than is required for those cancer treatment medications that are injected or intravenously administered by a health care provider, regardless of the formulation or benefit category.

B. A group or blanket disability insurer may not avoid compliance with subsection A of this section by:

1. Increasing the copayment, deductible or coinsurance amount required for covered cancer treatment medications that are injected or intravenously administered by a health care provider.

2. Reclassifying benefits with respect to cancer treatment medications for compliance with subsection A of this section.

C. For the purposes of this section, "cancer treatment medications" means prescription drugs and biologics that are used to kill, slow or prevent the growth of cancerous cells.

Sec. 5. Short title

This act may be cited as the "Fair Access to Cancer Treatment Act".